Abstract:We tested the hypothesis that mast cells contribute to platelet-activating factor (PAF)-induced airways hyperreactivity and hyperpermeability in mice. Airways reactivity to acetylcholine (ACh) and lung permeability to Evans blue (EB) dye were measured before and after PAF challenge in genetically mast cell-deficient (WBB6F1 W/Wv) and normal congenic (WBB6F1 +/+) mice, as well as mast cell-reconstituted (BMT W/Wv) mice. In addition, prostaglandin D2 (PGD2), a mast cell-specific mediator, was measured in the bronchoalveolar lavage (BAL) from +/+ and W/Wv mice to determine if lung mast cell activation was a consequence of PAF challenge. Genetically PAF-sensitive AKR/J mice were also treated with the mast cell stabilizer nedocromil prior to assessment of PAF effects on ACh reactivity. Intravenous PAF (10 micrograms/kg) induced a significant (P < 0.05) increase in airways reactivity to ACh (25 micrograms/kg) in both +/+ (371 +/- 52%) and W/Wv (122 +/- 24%) mice. There was a significantly greater increase in +/+ compared with W/Wv mice. PAF-induced hyperreactivity to ACh in BMT W/Wv mice (191 +/- 44%) was significantly (P < 0.05) greater than age-matched W/Wv mice (80 +/- 16%), but not significantly different from age-matched +/+ mice (153 +/- 44%). PAF (10 micrograms/kg) also significantly (P < 0.5) increased lung permeability in +/+ and W/Wv mice, but there was no significant difference between groups. BAL PGD2 increased significantly in +/+ mice following PAF challenge (559 +/- 24 ng/ml) compared with vehicle controls (152 +/- 8 pg/ml). There was no significant increase in BAL PGD2 from W/Wv mice. Nedocromil pretreatment significantly (P < 0.05) decreased PAF-induced hyperreactivity in AKR/J mice but not in W/Wv mice (P > 0.05). We conclude that mast cells contribute significantly to PAF-induced hyperreactivity but not hyperpermeability in mice.

Effects of platelets on histamine release of mast cell and influence of sodium ferulate

Endothelium-independent vasorelaxant effect of sodium ferulate on rat thoracic aorta

Effects of different concentrations of peptidoglycan,lipopolysaccharides,polyinosinic polycytidylic acid on histamine releasing property of basophils in allergic asthma patients

The Effects Of Overexpression Of Histamine Releasing Factor (Hrf) In A Transgenic Mouse Model

Determination of the Platelet Activating Factor in Silicotic Patients and Its Effect on Fibroblasts

The Inhibition Of Mast Cell Activation Of Radix Paeoniae Alba Extraction Identified By Tcrp Based And Conventional Cell Function Assay Systems

Inhibitory Effects of Two Ferulates from Angelica Sinensis on Platelet Aggregation and Oxytocin-induced Uterine Contraction

Experimental Study on Effect of Antagonizing Platelet-Activating Factor and Histamine of Synthetic Ginkgolide F in Guinea-Pigs

Platelets, Not an Insignificant Player in Development of Allergic Asthma

Potential regulatory effects of histamine by intracerebroventricularly administration on asthma-like reaction in rats

PAF-induced airways hyperreactivity is modulated by mast cells in mice

The Effects of Platelet-Activating-Factor and Retinoic Acid on the Expression of Elam-1 and Icam-1 and the Functions of Neutrophils

Effect of safflower yellow on platelet activating factor mediated platelet activation in patients with coronary heart disease

The Anti-Anaphylactoid Effects of Hydroxysafflor Yellow A on the Suppression of Mast Cell Ca2+ Influx and Degranulation.

Ferroptotic alveolar epithelial type II cells drive T H 2 and T H 17 mixed asthma triggered by birch pollen allergen Bet v 1

The Effects of Thermal Stimuli on Intracellular Calcium Change and Histamine Releases in Rat Basophilic Leukemia Mast Cells

Comparison of Basophils Release-ability Using PGN, LPS or Poly I:C Stimulator in Patients with Allergic Asthma

The inhibitory effect of hydrogen sulfide on platelet aggregation and the underlying mechanisms

Study of the Effect of S.Przewalskii Maxim var Mandarinorum Stib on Platelet Function in Rabbits

Effect of Fagopyri Dibotryis Rhizoma Extracts on Mast Cells Protease Activated Receptor 2 and Substance P in Rat Models of Irritable Bowel Syndrome